Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer

Status unconfirmed · Not applicable

Conditions studied: Ovarian Cancer

In brief

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for ovarian cancer. PURPOSE: Screening trial to determine the significance of cancer antigen 125 (CA125) levels in detecting ovarian cancer in participants who have a high genetic risk of developing ovarian cancer.

Key facts

Study ID

NCT00039559

Run by

Massachusetts General Hospital

People needed

2430

Starts

2002-05-01

Expected to finish

2014-12-01

Last updated by the study team

2013-06-10

Who can join

Age: 30 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• M. D. Anderson Cancer Center at University of Texas — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.